BT8009, Zelenectide Pevedotin, PEMBROLIZUMAB
BT8009-100
Phase 2 small_molecule active
Quick answer
BT8009, Zelenectide Pevedotin, PEMBROLIZUMAB for Nectin-4 Expressing Advanced Malignancies. is a Phase 2 program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BICYCLE THERAPEUTICS
- Indication
- Nectin-4 Expressing Advanced Malignancies.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active